These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29399152)

  • 1. CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.
    Jayaraman S; Doucet M; Kominsky SL
    Oncol Lett; 2018 Jan; 15(1):871-878. PubMed ID: 29399152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
    Jayaraman S; Doucet M; Kominsky SL
    Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
    Jayaraman S; Doucet M; Lau WM; Kominsky SL
    Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
    Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
    Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
    Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
    Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
    Tang Z; He G; Xu J; Zhongfu L
    J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
    Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
    Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CITED2 limits pathogenic inflammatory gene programs in myeloid cells.
    Pong Ng H; Kim GD; Ricky Chan E; Dunwoodie SL; Mahabeleshwar GH
    FASEB J; 2020 Sep; 34(9):12100-12113. PubMed ID: 32697413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CITED2 in stem cells and cancer.
    An B; Ji X; Gong Y
    Oncol Lett; 2020 Oct; 20(4):107. PubMed ID: 32831926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CITED2 and the modulation of the hypoxic response in cancer.
    Fernandes MT; Calado SM; Mendes-Silva L; Bragança J
    World J Clin Oncol; 2020 May; 11(5):260-274. PubMed ID: 32728529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
    Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.
    Tanaka T; Yamaguchi J; Higashijima Y; Nangaku M
    FASEB J; 2013 Oct; 27(10):4059-75. PubMed ID: 23792300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
    Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
    Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
    Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
    Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
    Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
    Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9 Knockdown-Mediated FOXO3 Downregulation Confers Neuroprotection Against Ischemic Brain Injury.
    Deng Y; Ma G; Gao F; Sun X; Liu L; Mo D; Ma N; Song L; Huo X; He H; Miao Z
    Front Cell Dev Biol; 2020; 8():555175. PubMed ID: 33791290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas.
    Daino K; Roch-Lefevre S; Ugolin N; Altmeyer-Morel S; Guilly MN; Chevillard S
    Biochem Biophys Res Commun; 2009 Dec; 390(3):654-8. PubMed ID: 19825367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.